New Studies Showed Mixed-But-Promising Results for New Lupus Drug Anifrolumab
Lupus patients have been waiting a while for some good news. Only one drug, belimumab…
March 2021
dearfibromyalgia Nearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping It
“Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.” In…
Vagus Nerve Stimulation: A New Way to Treat Rheumatoid Arthritis
Some people with rheumatoid arthritis (RA) take a disease-modifying antirheumatic drug (DMARD) and/or a biologic…
Taking Hydroxychloroquine for RA or Lupus Can Reduce Heart Risk by 17%
The anti-malarial drug lowers cholesterol and blood sugar makes blood less sticky, which is good…
More Than 75% of Arthritis Patients Don’t Get Hepatitis Screening Before Starting a Biologic
Screening is important because silent hepatitis B and C infections can spring to life when…
Nearly 40% of Fibromyalgia Patients May Have a History of Being Abused
A new study adds support to the theory that psychological stress might increase the risk…
Osteoarthritis Risk Factors and Causes You Need to Know About
Osteoarthritis is the most common and well-known type of arthritis. It’s largely a wear-and-tear form…
Could the Weather Affect Lupus Symptoms? New Study Suggests Warm, Humid Weather Does
As the temperature increased, so did the risk of rash, joint inflammation, kidney problems, and…
Have Asthma or COPD? You Could Have a Higher Risk of Rheumatoid Arthritis
Researchers hope that identifying the link between respiratory issues and RA will result in better…
If You’re in Remission on a DMARD for Rheumatoid Arthritis, Should You Taper? Here’s What New Research Says
New data compares what happens when the dosage of DMARDs such as methotrexate is tapered…